Stockscreener 앱 받기
2.36
1.26%
-0.03
시간 외 거래:
2.36
전일 마감가:
$2.39
열려 있는:
$2.33
하루 거래량:
245.57K
Relative Volume:
2.33
시가총액:
$96.77M
수익:
$2.70M
순이익/손실:
$5.53M
주가수익비율:
21.45
EPS:
0.11
순현금흐름:
$-10.55M
1주 성능:
-0.42%
1개월 성능:
-3.28%
6개월 성능:
+1.72%
1년 성능:
+1.72%
1일 변동 폭
$2.29
$2.39
1주일 범위
$2.29
$2.42
52주 변동 폭
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
명칭
Oramed Pharmaceuticals Inc
전화
646-844-1164
주소
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
ORMP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.36 | 98.00M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-12 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-20 | 개시 | Canaccord Genuity | Buy |
| 2021-02-09 | 개시 | National Securities | Buy |
| 2020-12-03 | 개시 | Alliance Global Partners | Buy |
| 2020-03-11 | 개시 | Aegis Capital | Buy |
| 2019-09-11 | 개시 | Ladenburg Thalmann | Buy |
| 2017-12-11 | 재개 | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | 재확인 | FBR Capital | Outperform |
| 2015-12-01 | 재확인 | H.C. Wainwright | Buy |
| 2015-11-19 | 개시 | FBR Capital | Outperform |
| 2015-04-13 | 재개 | MLV & Co | Buy |
| 2014-01-30 | 재확인 | Aegis Capital | Buy |
| 2014-01-08 | 재확인 | Aegis Capital | Buy |
| 2014-01-08 | 개시 | MLV & Co | Buy |
| 2013-12-03 | 개시 | Aegis Capital | Buy |
모두보기
Oramed Pharmaceuticals Inc 주식(ORMP)의 최신 뉴스
Oramed Pharmaceuticals Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Is Oramed Pharmaceuticals Inc. stock a top pick in earnings seasonJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Ranking Oramed Pharmaceuticals Inc. among high performing stocks via toolsEarnings Overview Report & Precise Trade Entry Recommendations - newser.com
How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil markets2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
What sentiment indicators say about Oramed Pharmaceuticals Inc. stockWeekly Investment Report & Community Trade Idea Sharing - newser.com
What does recent volatility data suggest for Oramed Pharmaceuticals Inc.July 2025 Update & Trade Opportunity Analysis - newser.com
Published on: 2025-11-03 04:30:55 - newser.com
Applying sector rotation models to Oramed Pharmaceuticals Inc.July 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com
Using Ichimoku Cloud for Oramed Pharmaceuticals Inc. technicalsDay Trade & Precise Buy Zone Tips - newser.com
What insider trading reveals about Oramed Pharmaceuticals Inc. stockJuly 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
Why Oramed Pharmaceuticals Inc. (OJU1) stock fits value portfolios2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Why Oramed Pharmaceuticals Inc. stock is a must watch in 20252025 Valuation Update & Community Supported Trade Ideas - newser.com
Is Oramed Pharmaceuticals Inc a good long term investmentMoving Average Strategies & Superior Growth Investment - earlytimes.in
Is Oramed Pharmaceuticals Inc. stock a defensive play in 20252025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Pattern recognition hints at Oramed Pharmaceuticals Inc. upsideQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
Will Oramed Pharmaceuticals Inc. benefit from macro trends2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
How Oramed Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthEarnings Miss & Real-Time Volume Trigger Notifications - newser.com
Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Hold at Wall Street Zen - MarketBeat
Is Oramed Pharmaceuticals Inc. (OJU1) stock resilient in recession scenariosWeekly Volume Report & Growth Focused Investment Plans - newser.com
Custom watchlist performance reports with Oramed Pharmaceuticals Inc.Weekly Volume Report & Real-Time Volume Trigger Notifications - newser.com
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversal2025 Price Action Summary & AI Driven Price Forecasts - newser.com
What recovery options are there for Oramed Pharmaceuticals Inc.July 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Will Oramed Pharmaceuticals Inc. stock continue upward momentumEarnings Miss & Real-Time Sentiment Analysis - newser.com
Will breakout in Oramed Pharmaceuticals Inc. lead to full recoveryJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Tools to assess Oramed Pharmaceuticals Inc.’s risk profileJuly 2025 Technicals & High Conviction Buy Zone Alerts - newser.com
Oramed Pharmaceuticals Inc (ORMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):